Related Experiment Videos
Prevention of immune precipitation by purified classical pathway complement components
Insights
The classical complement pathway prevents immune precipitation. Intact C1 is crucial, but its enzymatic activity is not required, demonstrating classical pathway activation is sufficient.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Immune precipitation is a critical process in immune complex clearance.
- The classical complement pathway's role in modulating immune precipitation requires further elucidation.
Purpose of the Study:
- To investigate the role of the classical complement pathway in preventing immune precipitation.
- To determine which components of the classical pathway are essential for this function.
Main Methods:
- Utilized purified complement components and immune complexes (IC) comprising rabbit anti-BSA and BSA.
- Assessed the effect of C1, C1q, EDTA-treated C1, C1-inhibitor treated C1, C4, C2, and C3 on IC precipitation rates.
- Employed protease inhibitors (phenylmethylsulphonyl fluoride and benzamidine) to probe the enzymatic site's involvement.
Main Results:
- The intact C1 molecule significantly reduced the rate of immune precipitation.
- C1q, EDTA-treated C1, or C1-inhibitor treated C1 did not inhibit precipitation, indicating the necessity of intact C1.
- The enzymatic site of C1 was not required for its anti-precipitation activity.
- C4 and C2 showed no significant effect on precipitation when C1 was present.
- Addition of C3 to C1, C4, and C2 completely prevented IC precipitation.
Conclusions:
- The classical complement pathway, specifically intact C1, plays a vital role in preventing immune precipitation.
- Classical pathway activation alone is sufficient to inhibit immune precipitation, with C3 being a key effector.
- The anti-precipitation function of C1 does not rely on its enzymatic activity.
Abstract:
The role of the classical pathway of complement in the prevention of immune precipitation has been investigated using purified complement components and immune complexes (IC) consisting of rabbit anti-BSA and BSA. C1 reduced the rate of immune precipitation. As C1q, EDTA treated C1 or C1-inhibitor treated C1 were unable to retard the precipitation of IC, it was concluded that the intact C1 molecule was required for this function. Use of phenylmethylsulphonyl fluoride and benzamidine showed that the enzymatic site on C1 was not required for this activity. C4 and C2 did not affect immune precipitation significantly when C1 was present at the concentrations present in serum. When C3 was added to C1, C4 and C2 precipitation of IC did not occur. These data demonstrate that classical pathway activation alone is sufficient for the prevention of immune precipitation.